FOXO3: A master switch for regulating tolerance and immunity in dendritic cells

Por Watkins, Stephanie K., Hurwitz, Arthur A.
Publicado em 2012

Combination Immunotherapy of B16 Melanoma Using Anti–Cytotoxic T Lymphocyte–Associated Antigen 4 (Ctla-4) and Granulocyte/Macrophage Colony-Stimulating Factor (Gm-Csf)-Producing Va...

Por van Elsas, Andrea, Hurwitz, Arthur A., Allison, James P.
Publicado em 1999

Isolation of Immune Cells from Primary Tumors

Por Watkins, Stephanie K., Zhu, Ziqiang, Watkins, Keith E., Hurwitz, Arthur A.
Publicado em 2012

T Cell Avidity and Tumor Immunity: Problems and Solutions

Por Hurwitz, Arthur A., Cuss, Steven M., Stagliano, Katherine E., Zhu, Ziqiang
Publicado em 2013

Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice

Por Hurwitz, Arthur A., Sullivan, Timothy J., Sobel, Raymond A., Allison, James P.
Publicado em 2002

The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells

Por Wuest, Thomas Y., Willette-Brown, Jami, Durum, Scott K., Hurwitz, Arthur A.
Publicado em 2008

Melanoma Progression Despite Infiltration by in vivo-Primed TRP-2-Specific T Cells

Por Singh, Vinod, Ji, Qingyong, Feigenbaum, Lionel, Leighty, Robert M., Hurwitz, Arthur A
Publicado em 2009

CTLA-4 blockade synergizes with tumor-derived granulocyte– macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma

Por Hurwitz, Arthur A., Yu, Tina F.-Y., Leach, Dana R., Allison, James P.
Publicado em 1998

High Avidity T cells are Preferentially Tolerized in the Tumor Microenvironment

Por Zhu, Ziqiang, Singh, Vinod, Watkins, Stephanie K., Bronte, Vincenzo, Shoe, Jennifer L., Feigenbaum, Lionel, Hurwitz, Arthur A.
Publicado no Cancer Res (2012)

Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy

Por Kwon, Eugene D., Foster, Barbara A., Hurwitz, Arthur A., Madias, Chris, Allison, James P., Greenberg, Norman M., Burg, Maurice B.
Publicado em 1999

29(th) Annual meeting of the Society for Immunotherapy of Cancer (SITC)

Por Hurwitz, Arthur A, Lee, Sylvia, Knox, Susan, Kohrt, Holbrook, Verdeil, Gregory, Romano, Emanuela, Margolin, Kim, Urba, Walter J, Speiser, Daniel E
Publicado no J Immunother Cancer (2015)

Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer

Por Kwon, Eugene D., Hurwitz, Arthur A., Foster, Barbara A., Madias, Christopher, Feldhaus, Andrew L., Greenberg, Norman M., Burg, Maurice B., Allison, James P.
Publicado em 1997

Immunity to Murine Prostatic Tumors: Continuous Provision of T Cell Help Prevents CD8 T Cell Tolerance and Activates Tumor-Infiltrating Dendritic Cells

Por Shafer-Weaver, Kimberly A., Watkins, Stephanie K., Anderson, Michael J., Draper, Lauren J., Malyguine, Anatoli, Alvord, W. Gregory, Greenberg, Norman M., Hurwitz, Arthur A.
Publicado em 2009

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

Por Watkins, Stephanie K., Zhu, Ziqiang, Riboldi, Elena, Shafer-Weaver, Kim A., Stagliano, Katherine E.R., Sklavos, Martha M., Ambs, Stefan, Yagita, Hideo, Hurwitz, Arthur A.
Publicado em 2011

FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer

Por Watkins, Stephanie K., Zhu, Ziqiang, Riboldi, Elena, Shafer-Weaver, Kim A., Stagliano, Katherine E.R., Sklavos, Martha M., Ambs, Stefan, Yagita, Hideo, Hurwitz, Arthur A.
Publicado no J Clin Invest (2015)

Development of regulatory T cells requires IL-7Rα stimulation by IL-7 or TSLP

Por Mazzucchelli, Renata, Hixon, Julie A., Spolski, Rosanne, Chen, Xin, Li, Wen Qing, Hall, Veronica L., Willette-Brown, Jami, Hurwitz, Arthur A., Leonard, Warren J., Durum, Scott K.
Publicado em 2008

Immunotherapy-induced CD8(+) T Cells Instigate Immune Suppression in the Tumor

Por McGray, A J Robert, Hallett, Robin, Bernard, Dannie, Swift, Stephanie L, Zhu, Ziqiang, Teoderascu, Florentina, VanSeggelen, Heather, Hassell, John A, Hurwitz, Arthur A, Wan, Yonghong, Bramson, Jonathan L
Publicado em 2014

Elucidating the Autoimmune and Antitumor Effector Mechanisms of a Treatment Based on Cytotoxic T Lymphocyte Antigen-4 Blockade in Combination with a B16 Melanoma Vaccine: Compariso...

Por van Elsas, Andrea, Sutmuller, Roger P.M., Hurwitz, Arthur A., Ziskin, Jennifer, Villasenor, Jennifer, Medema, Jan-Paul, Overwijk, Willem W., Restifo, Nicholas P., Melief, Cornelis J.M., Offringa, Rienk, Allison, James P.
Publicado em 2001

MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer

Por Hudson, Robert S., Yi, Ming, Esposito, Dominic, Glynn, Sharon A., Starks, Adrienne M., Yang, Yinmeng, Schetter, Aaron J., Watkins, Stephanie K., Hurwitz, Arthur A., Dorsey, Tiffany H., Stephens, Robert M., Croce, Carlo M., Ambs, Stefan
Publicado em 2012

MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer

Por Hudson, Robert S., Yi, Ming, Esposito, Dominic, Watkins, Stephanie K., Hurwitz, Arthur A., Yfantis, Harris G., Lee, Dong H., Borin, James F., Naslund, Michael J., Alexander, Richard B., Dorsey, Tiffany H., Stephens, Robert M., Croce, Carlo M., Ambs, Stefan
Publicado em 2012